Drug
Gzr18 A
Gzr18 A: highest development phase Phase 1, developed by Gan & Lee Pharmaceuticals.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Gan & Lee Pharmaceuticals.
Trials
| Drug | Phase | Indication |
|---|---|---|
| GZR18 injection A NCT07355738 | Phase 1 | Obesity&T2D |
Latest
No recent events.
Follow Gzr18 A on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.